CAS: 1206711-16-1; 4-(6-(4-Isopropoxyphenyl)Pyrazolo[1,5-A]Pyrimidin-3-yl)Quinoline

该化合物是一种合成有机化合物,属于一种类型的杂交循环化合物.该物质具有复杂的分子结构,其中包括一种与一种正对子-旋律-旋律粘合在一起的quinline核心,有助于其潜在的生物活动.一甲基乙氧基组的存在,增强了其亲脂性,有可能影响其溶性及在生物系统中的渗透性.这种化合物经常因其药用性质而受到调查,包括防炎,抗癌或抗微生物活动.分子的功能组的具体安排和三维整体相容性可以极大地影响其与生物目标的相互作用,使其成为对医药化学的兴趣对象.与许多合成化合物一样,了解其稳定性,再活性和潜在毒性对于评估其在研究和治疗环境中的适用性至关重要.

结构式图片

欧盟法规

ECHA物质C&L通报

合成工艺路线路线简述

    海关参考信息

    专利信息


    专利号:US-2025177964-A1
    优先权日:2023-11-30
    标题 :Synthesis procedure of homopolymers and copolymers based on vinyl ionic liquids, n-vinylpyrrolidone or vinylpyridine and the methodology for their application as catalysts in alkylation reactions of isoparaffins and olefins
    发明人:PAZ ARACELI VEGA; DOMà NGUEZ MERCEDES BAZALDUA; LUCERO DIEGO JAVIER GUZMà N; CORTEZ JOSÉ GONZALO HERNà NDEZ; ROBLES NOHEMà ORNELAS; PANTOJA JAVIER GUZMà N; PALOU RAFAEL MARTà NEZ
    权利人:MEXICANO INST PETROL
    摘要:The present disclosure relates to a procedure for the synthesis of polymers (homo and copolymers) of the poly (ionic liquid) (PIL) type. The homopolymers are derived from polyvinylimidazolium, polyvinylpyrrolidone or polyvinylpyridine and the copolymers from monomers of vinyl ionic liquids (ILs) are derived from imidazole and N-vinylpyrrolidone. The structural modification of these homopolymers and copolymers occurs by using strong inorganic acids such as sulfuric, chlorosulfonic and bromosulfonic, among others, and halide metallic salts such as AlCl3, FeCl3, CuCl, ZnCl2, and SnCl2. Also, these PILs are employed as catalysts in alkylation reactions between isoparaffins and olefins for producing alkylate gasoline.

    专利号:US-6696438-B2
    优先权日:1998-06-22
    标题:Cyclic amino acid compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds
    发明人:AUDIA JAMES E; DRESSMAN BRUCE A; SHI QING
    权利人:ELAN PHARM INC; LILLY CO ELI
    摘要:Disclosed are compounds which inhibit β-amyloid peptide release and/or its synthesis, and, accordingly, have utility in treating Alzheimer's disease. Also disclosed are pharmaceutical compositions comprising a compound which inhibits β-amyloid peptide release and/or its synthesis as well as methods for treating Alzheimer's disease both prophylactically and therapeutically with such pharmaceutical compositions.

    专利号:US-2003162768-A1
    优先权日:1998-06-22
    标 题:Cyclic amino acid compounds, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献


    1: Owens P, Pickup MW, Novitskiy SV, Giltnane JM, Gorska AE, Hopkins CR, Hong CC, Moses HL. Inhibition of BMP signaling suppresses metastasis in mammary cancer. Oncogene. 2014 Jul 7. doi: 10.1038/onc.2014.189. [Epub ahead of print] doi: 10.1371/journal.pone.0090748. eCollection 2014.
    5: Matsumoto Y, Hayashi Y, Schlieve CR, Ikeya M, Kim H, Nguyen TD, Sami S, Baba S, Barruet E, Nasu A, Asaka I, Otsuka T, Yamanaka S, Conklin BR, Toguchida J, Hsiao EC. Induced pluripotent stem cells from patients with human fibrodysplasia ossificans progressiva show increased mineralization and cartilage formation. Orphanet J Rare Dis. 2013 Dec 9;8:190. doi: 10.1186/1750-1172-8-190.
    6: Chang HM, Cheng JC, Klausen C, Leung PC. BMP15 suppresses progesterone production by down-regulating StAR via ALK3 in human granulosa cells. Mol Endocrinol. 2013 Dec;27(12):2093-104. doi: 10.1210/me.2013-1233. Epub 2013 Oct 18. doi: 10.1016/j.bbrc.2013.05.113. Epub 2013 Jun 6. doi: 10.1016/j.bmcl.2013.03.113. Epub 2013 Apr 11.

    合成参考文献


    参考文献:10.1021/cb9002865
    摘要:Hao J, Ho JN, Lewis JA, Karim KA, Daniels RN, Gentry PR, Hopkins CR, Lindsley CW, Hong CC. In vivo structure-activity relationship study of dorsomorphin analogues identifies selective VEGF and BMP inhibitors. ACS Chem Biol. 2010 Feb 19;5(2):245–53.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知